MX9300035A - TREATMENT OF INVOLUNTARY MOVEMENT WITH 5HT1A RECEIVER AGONISTS. - Google Patents

TREATMENT OF INVOLUNTARY MOVEMENT WITH 5HT1A RECEIVER AGONISTS.

Info

Publication number
MX9300035A
MX9300035A MX9300035A MX9300035A MX9300035A MX 9300035 A MX9300035 A MX 9300035A MX 9300035 A MX9300035 A MX 9300035A MX 9300035 A MX9300035 A MX 9300035A MX 9300035 A MX9300035 A MX 9300035A
Authority
MX
Mexico
Prior art keywords
5ht1a
treatment
involuntary movement
agonists
receiver agonists
Prior art date
Application number
MX9300035A
Other languages
Spanish (es)
Inventor
Martin Galvan
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of MX9300035A publication Critical patent/MX9300035A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Abstract

Está invención se refiere a nuevos usos de una clase conocida de agonistas de receptores 5HT1A y a la obtención de estos compuestos conocidos para su uso como medicamentos para nuevos usos.This invention relates to new uses of a known class of 5HT1A receptor agonists and to the preparation of these known compounds for use as medicaments for new uses.

MX9300035A 1992-01-07 1993-01-07 TREATMENT OF INVOLUNTARY MOVEMENT WITH 5HT1A RECEIVER AGONISTS. MX9300035A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92400032 1992-01-07

Publications (1)

Publication Number Publication Date
MX9300035A true MX9300035A (en) 1994-05-31

Family

ID=8211593

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300035A MX9300035A (en) 1992-01-07 1993-01-07 TREATMENT OF INVOLUNTARY MOVEMENT WITH 5HT1A RECEIVER AGONISTS.

Country Status (5)

Country Link
AU (1) AU3241093A (en)
CA (1) CA2126554A1 (en)
MX (1) MX9300035A (en)
WO (1) WO1993013766A1 (en)
ZA (1) ZA9312B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919802A (en) * 1997-12-05 1999-07-06 Princeton University Methods of preventing and/or treating temporal lobe epilepsy
GB0027020D0 (en) * 2000-11-03 2000-12-20 Univ Manchester Treatment of movement disorders
AR049478A1 (en) 2004-03-25 2006-08-09 Solvay Pharm Bv A PROCEDURE FOR THE PREPARATION OF 3-AMINO-8- (1-PIPERAZINIL) -2H-1-BENZOPIRAN-2-ONA. SALTS AND HYDRATES AND PHARMACEUTICAL COMPOSITIONS.
US20050215551A1 (en) * 2004-03-25 2005-09-29 Solvay Pharmaceuticals B.V. 1-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disorders
US9066903B2 (en) 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease
HUE039750T2 (en) * 2014-06-26 2019-02-28 Contera Pharma Aps 6-hydroxybuspirone for use in the treatment of movement disorders
CN111116451A (en) * 2020-01-16 2020-05-08 宁波大学 Polysubstituted tryptophane benzamide compound and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642497A1 (en) * 1986-12-12 1988-06-23 Hoechst Ag SUBSTITUTED AMINOPROPIONIC ACID AMIDES, METHOD FOR THE PRODUCTION THEREOF, THEIR SUBSTANCES AND THEIR USE AND THE NEW INTERMEDIATES PRODUCED IN THE PRODUCTION

Also Published As

Publication number Publication date
ZA9312B (en) 1993-08-05
WO1993013766A1 (en) 1993-07-22
AU3241093A (en) 1993-08-03
CA2126554A1 (en) 1993-07-22

Similar Documents

Publication Publication Date Title
ES2192301T3 (en) RESORCINOL DERIVATIVES
ES550807A0 (en) A PROCEDURE FOR THE PRODUCTION OF A PHARMACEUTICAL PREPARATION FOR SLOW AND CONTROLLED RELEASE.
AR008991A1 (en) DIMETHYL- (3-ARYL-BUT-3-ENYL) -AMINE COMPOUNDS, PROCEDURES FOR THEIR PREPARATION AND APPLICATION OF THEM
ES2144192T3 (en) NEW DERIVATIVES OF 1-PHENYL-2-DIMETHYL-AMINO-METHYL-CICLOHEXAN-1-OL, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ES2111092T3 (en) DERIVATIVES OF BILIAR ACIDS, PROCEDURE FOR THE PREPARATION AND USE OF THESE COMPOUNDS AS MEDICINES.
ES2161085T3 (en) FORMULATIONS CONTAINING OXALIPLATIN.
ES2045110T3 (en) IMPROVEMENTS IN OR RELATED TO LEUCOTRENE ANTAGONISTS.
SV1999000016A (en) DERIVATIVES OF 2- (PURIN-9-IL-TETRAHIDROFURAN-3,4-DIOL REF. PG3443 / SV
MX9300407A (en) AZABICICLIC DERIVATIVES USED IN THE MANUFACTURE OF MEDICINES, CONTAINING COMPOSITIONS AND PROCEDURE FOR THE PREPARATION.
ES2039198T3 (en) PROCEDURE TO PREPARE 5-AMINO AND 5-HYDROXY-6,8-DIFLUORQUINOLONES AS ANTIBACTERIAL AGENTS.
ES2172937T3 (en) 21-HYDROXI-6,19-OXIDOPROGESTERONE (21OH-6OP) AS A MEDICINAL PRODUCT TO TREAT THE EXCESS OF GLUCOCORTICOIDS.
AR241082A1 (en) NEW USEFUL PIRAZOL DERIVATIVES AS HERBICIDE AGENTS, THE HERBICIDE COMPOSITIONS CONTAINING THEM AND THE PROCEDURES FOR PRODUCING THESE PIRAZOLE DERIVATIVES. "
BR8800918A (en) COMPOSITION FOR COSMETIC BASIS OF GEL, TRANSLUCIDO, TRANSPARENTE
MX9300035A (en) TREATMENT OF INVOLUNTARY MOVEMENT WITH 5HT1A RECEIVER AGONISTS.
ES551788A0 (en) PROCEDURE TO PREPARE NEW BENZAZEPINE DERIVATIVES.
ES2156255T3 (en) PROCEDURE FOR PREPARING ANTAGONISTS OF THE FIBRINOGEN RECEIVER.
ECSP034530A (en) DERIVATIVES OF 6-METHYL-TRAMADOL REPLACED IN OR
ES2135412T3 (en) USE OF ANTAGONISTS OR PARTIAL AGONISTS OF THE 5-HT 1A RECEPTOR FOR THE TREATMENT AND PREVENTION OF COGNITIVE DISORDERS.
ES2179857T3 (en) SUBSTITUTED QUINOLEINE DERIVATIVES, PROCEDURE FOR PREPARATION AND USE.
ES2054881T3 (en) PANTETINE AS AN INHIBITING AGENT FOR HEPATIC FIBROSIS.
MX9300406A (en) AZABICICLIC DERIVATIVES PROCEDURES FOR ITS PREPARATION AND COMPOSITIONS THAT CONTAIN THEM.
AR059965A2 (en) USE OF 8,9-DEHYDROESTRONE FOR THE PREPARATION OF AN ANTIOXIDANT MEDICINAL PRODUCT
ES2166026T3 (en) DERIVATIVES OF 1,2,3-BENZOTIADIAZOL AND ITS USE AS MICROBICIDES.
MX9207264A (en) SULFONIMIDAMIDE COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM
ES2131850T3 (en) USE OF SUBSTITUTED 6-AMINO-4H-PYRANS.